pubmed-article:14630536 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14630536 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:14630536 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:14630536 | lifeskim:mentions | umls-concept:C0021753 | lld:lifeskim |
pubmed-article:14630536 | lifeskim:mentions | umls-concept:C0021760 | lld:lifeskim |
pubmed-article:14630536 | lifeskim:mentions | umls-concept:C1882598 | lld:lifeskim |
pubmed-article:14630536 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
pubmed-article:14630536 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:14630536 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:14630536 | pubmed:dateCreated | 2003-11-21 | lld:pubmed |
pubmed-article:14630536 | pubmed:abstractText | To evaluate the central nervous system neuroimmune and inflammatory responses during the prodromal phase of the acute irradiation syndrome in rat brains after partial-body exposure (head-protected) and to investigate the potential neural signalling pathways from the irradiated periphery to the non-irradiated brain. | lld:pubmed |
pubmed-article:14630536 | pubmed:language | eng | lld:pubmed |
pubmed-article:14630536 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14630536 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14630536 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14630536 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14630536 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14630536 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14630536 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14630536 | pubmed:month | Oct | lld:pubmed |
pubmed-article:14630536 | pubmed:issn | 0955-3002 | lld:pubmed |
pubmed-article:14630536 | pubmed:author | pubmed-author:MathieuJJ | lld:pubmed |
pubmed-article:14630536 | pubmed:author | pubmed-author:LinardCC | lld:pubmed |
pubmed-article:14630536 | pubmed:author | pubmed-author:MarquetteCC | lld:pubmed |
pubmed-article:14630536 | pubmed:author | pubmed-author:Van UyeAA | lld:pubmed |
pubmed-article:14630536 | pubmed:author | pubmed-author:GourmelonPP | lld:pubmed |
pubmed-article:14630536 | pubmed:author | pubmed-author:ClarençonDD | lld:pubmed |
pubmed-article:14630536 | pubmed:author | pubmed-author:GalonnierMM | lld:pubmed |
pubmed-article:14630536 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14630536 | pubmed:volume | 79 | lld:pubmed |
pubmed-article:14630536 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14630536 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14630536 | pubmed:pagination | 777-85 | lld:pubmed |
pubmed-article:14630536 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:meshHeading | pubmed-meshheading:14630536... | lld:pubmed |
pubmed-article:14630536 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14630536 | pubmed:articleTitle | IL-1beta, TNFalpha and IL-6 induction in the rat brain after partial-body irradiation: role of vagal afferents. | lld:pubmed |
pubmed-article:14630536 | pubmed:affiliation | IRSN BP no. 17 F-92262 Fontenay aux Roses cedex France. christel.marquette@irsn.fr | lld:pubmed |
pubmed-article:14630536 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14630536 | pubmed:publicationType | Comparative Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14630536 | lld:pubmed |